Richard Vosser

Stock Analyst

(n/a)

# 4,650

Out of 4,652 analysts

10

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Richard Vosser

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MOLN Molecular Partners AG	Maintains: Neutral	$6.6 → $4.5	$5.82	-22.66%	1	Dec 5, 2023
	NVO Novo Nordisk	Upgrades: Overweight	n/a	$109.09	-	7	Jun 7, 2022
	SNY Sanofi	Upgrades: Overweight	n/a	$50.62	-	2	Jan 6, 2020

Molecular Partners AG

Dec 5, 2023

Maintains: Neutral

Price Target: $6.6 → $4.5

Current: $5.82

Upside: -22.66%

Novo Nordisk

Jun 7, 2022

Upgrades: Overweight

Price Target: n/a

Current: $109.09

Upside: -

Sanofi

Jan 6, 2020

Upgrades: Overweight

Price Target: n/a

Current: $50.62

Upside: -